EN DE
Watch China BlueChemical Ltd. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

China BlueChemical Ltd. (3983) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of China BlueChemical Ltd. stock HK$3.07, price HK$1.76, upside +74.9%, quality 59 out of 100. Rating: strongly undervalued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Basic Materials HK · Home China · ISIN CNE1000002D0

CB China BlueChemical Ltd. logo Thin data Nov 12, 2026

China BlueChemical Ltd.

3983 · HK

Cheap (43% below fair value) and solid company, but falling price: meets 2 of 3 rules.

Get notified free when this changes
Fair value HK$3.07 · Strongly undervalued 
Low debt 
Generates free cash flow 
7.3% dividend yield · Well covered
Ranks above peers (11/15) 
Even on cautious assumptions the value is 25% above the price (HK$2.20). 
Quality 59/100 
Thin margins · 7.1% net margin (TTM) 
Falling price (downtrend) 
Weak Growth (revenue 3y −5.5 %/yr in CNY) 
Narrow moat 35/100 · thin data
Thin data 
⟳ Cyclical
Watch China BlueChemical Ltd. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$3.27 HK$1.08 Fair Value HK$3.07 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.

How to read this chart

60‑month range HK$1.08 – HK$3.27 · fair‑value band HK$2.20 – HK$4.11 · the HK$1.76 price screens below the HK$3.07 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 12, 2026.

Follow China BlueChemical in your weekly email

Every Wednesday you see whether China BlueChemical is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

China BlueChemical Ltd., together with its subsidiaries, engages in the processing of natural gas and the development, production, and sale of chemical fertilizers and chemical products in the People's Republic of China and internationally.

Show moreShow less

The company operates through Urea, Methanol, Phosphorus and Compound Fertiliser, Acrylonitrile, and Others segments. It offers urea; methanol; phosphorus fertilizers, including mono-ammonium phosphate and di-ammonium phosphate; compound fertilizers; and acrylonitrile and related products.

The company also manufactures and sells chemical fertilizers, and woven plastic bags. In addition, it is involved in port operations; provision of transportation services and overseas shipping services; and trading of fertilizers, chemicals, and coal and coal products, as well as mining of coal.

Further, the company engages in mining and processing phosphorus; manufacturing and sales of phosphorus ore and chemical products; manufacture and sale of methanol; Manufacturing and sales of high-value fluorochemicals; woven plastic bags are made of plastic resins; and manufacturing and sale methyl methacrylate.

The company was founded in 2000 and is headquartered in Beijing, the People's Republic of China. China BlueChemical Ltd. operates as a subsidiary of China National Offshore Oil Corporation.

Stock analysis

China BlueChemical Ltd. (3983) currently trades at HK$1.76, while our model-based Fair Value estimate is HK$3.07, implying the stock looks roughly 43% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of HK$3.47 per share, and 21 of the 25 models we run sit above the HK$1.76 price.

Bear case: the Dividend Discount group reads lowest at HK$1.55, and 4 of the 25 models stay below the price. Data coverage for this calculation is low.

Scenario range: HK$2.20 (bear) to HK$4.11 (bull), the price of HK$1.76 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 59/100 (solid quality), in the Basic Materials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

China BlueChemical Ltd. reported revenue of 12.0B CNY in FY2025 versus 13.4B CNY in FY2021, a compound −2.6%/yr. Reported net income was 974M CNY in FY2025, compounding −10.2%/yr from FY2021.

Key figures

Market cap HK$8.1B (≈ $1.0B) Small · P/E ratio 8.9 · P/S ratio 0.72 · Dividend yield 7.3% · Net margin 8.1% · Return on equity 4.1% · Return on assets (EBIT) 6.4% (5-year average) · Operating margin 4.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 35 out of 100 (low confidence).

What moves the price

The share trades about 46% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at 17% fair-value upside, at 75%, 3983 screens cheaper than that median.

Fair Value models

Bear HK$2.20 Fair Value HK$3.07 Bull HK$4.11
Price HK$1.76 · Upside +74.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF HK$2.15 HK$2.86 HK$3.73 79
Growth DCF HK$2.18 HK$2.83 HK$3.58 78
Owner Earnings HK$3.18 HK$4.23 HK$5.50 75
All 25 models by family
DCF Models
FCF DCF HK$2.15 HK$2.86 HK$3.73 79
Owner Earnings HK$3.18 HK$4.23 HK$5.50 75
5Y Revenue Exit HK$1.89 HK$2.72 HK$3.73 71
5Y EBITDA Exit HK$2.27 HK$3.41 HK$4.66 73
5Y P/E Exit HK$2.49 HK$3.79 HK$5.07 69
10Y Revenue Exit HK$1.94 HK$2.65 HK$3.50 65
10Y EBITDA Exit HK$2.20 HK$3.07 HK$4.11 67
10Y P/E Exit HK$2.32 HK$3.29 HK$4.38 62
Earnings-Based
Graham-Dodd HK$1.69 HK$3.92 HK$5.03 63
PEG = 1.0 HK$1.69 HK$2.41 HK$3.13 55
EPV HK$1.05 HK$1.19 HK$1.30 74
Dividend Discount
Gordon GGM HK$1.07 HK$1.62 HK$2.14 66
DDM Multi-Stage HK$1.07 HK$1.47 HK$1.85 65
Multiples
P/E Multiple HK$3.17 HK$4.22 HK$5.28 63
P/S Multiple HK$3.17 HK$4.22 HK$5.28 58
P/B Multiple HK$1.89 HK$2.52 HK$3.15 55
EV/EBIT HK$1.77 HK$2.47 HK$3.18 66
EV/EBITDA HK$2.40 HK$3.31 HK$4.22 67
EV/Revenue HK$1.49 HK$2.27 HK$3.06 53
Asset-Based
NCAV (Graham) HK$1.74 HK$2.64 HK$3.30 54
Growth DCF
Growth DCF HK$2.18 HK$2.83 HK$3.58 78
Rev-Margin DCF HK$1.89 HK$2.76 HK$3.69 71
Economic Profit
Residual Income HK$3.47 HK$3.45 HK$3.59 74
ROIC Compounder HK$1.05 HK$1.19 HK$1.30 70
Growth Earnings
Growth-Adj P/E HK$2.43 HK$3.47 HK$4.50 65

Open the full fair value analysis →

Quality Score breakdown

Overall quality 59/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 30
How much profit the company makes from its sales and capital
Quality Growth 35
Are margins and returns getting better?
Cashflow 53
Do the profits arrive as real cash?
Financial strength 79
Debt, balance sheet and risk of trouble
Investment 88
Does it invest with discipline instead of growing at any price?
Low Volatility 65
How calm the share price moves, does not count
Price momentum 15
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 6
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+0.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.9%
Start year 2020 (pandemic). Over 10 years: +1.2% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.5%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+12.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+5.5%
Dividend (yield on the price)7.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5.5% vs 7.6%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → 7%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

Little optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
less than -40 %
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.

Watch 3983, get fair value alerts →

Compare China BlueChemical Ltd. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Agricultural Inputs · 175 stocks

Beats the industry median on 11/15 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 59 · Above median
Fair Value upside +74.9% · Top 25%
Profitability
Return on equity (12 months) 4.1% · Below median
Return on assets 3.9% · Above median
Net margin (12 months) 7.1% · Above median
Operating margin (12 months) 4.6% · Below median
Growth and dividend
Revenue growth (quarter YoY) −3.9% · Below median
Dividend yield (12 months) 7.3% · Top 25%
Balance sheet
Debt / equity 0.05× · Below median

Valuation Multiplesvs Agricultural Inputs median · lower = cheaper

P/E (12 months) 8.9× · Cheapest 25%
P/B 0.37× · Cheapest 25%
P/S (12 months) 0.58× · Cheaper than median
Price / free cash flow (fiscal year) 7.1× · Cheapest 25%
EV/EBITDA 6.7× · Cheaper than median
PEG 1.43× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 16
FUTURE (revenue growth)0 · sector 16
PAST (return on equity)16 · sector 25
HEALTH (low debt)98 · sector 97
DIVIDEND (yield)100 · sector 41

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Basic Materials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

China BlueChemical Ltd.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "China BlueChemical Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/3983

Frequently asked questions

Is China BlueChemical Ltd. (3983) overvalued or undervalued?
As of Nov 12, 2026, our model estimates a fair value of HK$3.07 versus a price of HK$1.76, about +75% upside (undervalued).
What is the fair value of 3983?
Our model-based fair value for China BlueChemical Ltd. is HK$3.07 (as of Nov 12, 2026), built from audited fundamentals. The current price: HK$1.76.
What is the quality score of 3983?
China BlueChemical Ltd. has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for China BlueChemical Ltd. (3983)?
Our model-based price target is the fair value of HK$3.07 (as of Nov 12, 2026) from 25 valuation models. Cautious scenario HK$2.20, optimistic scenario HK$4.11. It is a calculation from audited fundamentals, not an analyst target.
What is the China BlueChemical Ltd. stock forecast for 2026?
Our models put fair value at HK$3.07, about +75% upside versus a price of HK$1.76 (undervalued). Cautious scenario HK$2.20, optimistic scenario HK$4.11. The calculation is refreshed regularly with new filings.
What is the revenue of China BlueChemical Ltd. (3983)?
China BlueChemical Ltd. reported trailing-twelve-month revenue of about 11.8B CNY (latest available figure, as of Nov 12, 2026).
Does China BlueChemical Ltd. pay a dividend?
China BlueChemical Ltd. currently shows a dividend yield of 7.32% relative to its recent price (as of Nov 12, 2026).
How much is the dividend of China BlueChemical Ltd. (3983) and when is the ex-dividend date?
China BlueChemical Ltd. pays a dividend of HK$0.128 per share a year, a dividend yield of 7.3%. The last ex-dividend date was Jun 1, 2026. A dividend has been paid every year since at least 2007. The payout ratio is 57.1% of earnings. Free cash flow covers the dividend 1.73 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into China BlueChemical Ltd. (3983)?
Today's price is already fair in a discounted-cash-flow model if free cash flow at China BlueChemical Ltd. shrinks by more than 40 % per year for five years (discount rate 11.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew 2.9 % per year. As of Nov 12, 2026.
What discount rate (WACC) does the fair value of 3983 use?
Our models discount China BlueChemical Ltd. at 11.4 %: a base by market capitalisation (small), damped by beta 0.88, country premium for Hong Kong. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For China BlueChemical Ltd. that is less than minus 40 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.4 %) and the same formula as our fair value.
How much growth has China BlueChemical Ltd. (3983) delivered so far?
Over the past 5 years revenue at China BlueChemical Ltd. grew 2.9 % a year. The price currently implies free-cash-flow growth of less than minus 40 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of China BlueChemical Ltd. (3983) growing?
The median revenue growth in the sector is +8.8 % a year. That is the yardstick for the growth priced into China BlueChemical Ltd. (less than minus 40 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of China BlueChemical Ltd. (3983)?
The free-cash-flow yield on the price is 14.05 %: that much free cash flow China BlueChemical Ltd. produces per unit of market value. When it exceeds the discount rate of our models (11.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of China BlueChemical Ltd. (3983)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For China BlueChemical Ltd. it is HK$3.07 per share (as of Nov 12, 2026), against a price of HK$1.76. It is the blended result of 25 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is China BlueChemical Ltd. stock overvalued or undervalued in 2026?
As of Nov 12, 2026, 3983 trades below its calculated fair value: price HK$1.76, fair value HK$3.07, a gap of about +75% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 3983?
No. The price is what the market pays today (HK$1.76); the fair value is what the company's own numbers justify (HK$3.07). For China BlueChemical Ltd. the two are HK$1.32 per share apart. That gap is exactly why we show both numbers side by side.
How much is China BlueChemical Ltd. worth?
The market values China BlueChemical Ltd. at about HK$8.1B (market capitalisation, as of Nov 12, 2026). Per share that is HK$1.76; our models calculate a fair value of HK$3.07 per share.
What do the bullish and bearish scenarios say about 3983?
Our models span a range for China BlueChemical Ltd.: cautious scenario HK$2.20, base HK$3.07, optimistic HK$4.11 per share (as of Nov 12, 2026, price HK$1.76). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 3983?
China BlueChemical Ltd. trades at a price-to-earnings ratio of 8.9 (as of Nov 12, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of HK$3.07 is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2017 to 2025), reported earnings, FY2025 ex one-offs: 7.2. Other multiples: PEG 1.4, P/B 0.4, P/S 0.6, EV/EBITDA 6.7.
What is the PEG ratio of 3983?
The PEG ratio of China BlueChemical Ltd. is 1.43 (P/E divided by earnings growth, as of Nov 12, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of China BlueChemical Ltd. (3983)?
Balance-sheet figures for China BlueChemical Ltd. (as of Nov 12, 2026): return on equity 4.1%, debt of 0.05 per unit of equity. They feed the Quality Score of 59/100, which measures business quality independently of the share price.
How far is 3983 from its 52-week high?
China BlueChemical Ltd. trades at HK$1.76, about 46% below its 52-week high of HK$3.27 and 2% above the low of HK$1.73 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of HK$3.07 is for.
Which stocks are comparable to China BlueChemical Ltd.?
From the same area (Basic Materials) we also value Nutrien Ltd, Qinghai Salt Lake Industry Co, CF Industries Holdings, SABIC Agri-Nutrients Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is China BlueChemical Ltd. stock attractive at the current price?
The data as of Nov 12, 2026: price HK$1.76, calculated fair value HK$3.07 (+75%), Quality Score 59/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 3983 calculated?
We run China BlueChemical Ltd. through 25 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of HK$3.07 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. China BlueChemical Ltd. currently trades 43% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of China BlueChemical Ltd. (3983)?
The closing price on Nov 13, 2026 was HK$1.76. Our model-based fair value is HK$3.07, about +75% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with China BlueChemical Ltd. right now?
The price is below even our cautious bear case (HK$2.20). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (59/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (HK$2.20 to HK$4.11) leaves room in how you read the outcome.
Where does the earnings growth of China BlueChemical Ltd. (3983) come from?
Earnings per share at China BlueChemical Ltd. grew 12.9 % a year from 2014 to 2025. Broken into its drivers: revenue per share +1.5 %, EBIT margin −3.2 %, tax rate +1.1 %, residual (interest, one-offs) +13.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of China BlueChemical Ltd.

How large is the market capitalisation of China BlueChemical Ltd. (3983)?
The market capitalisation of China BlueChemical Ltd. is HK$8.1B (≈ $1.0B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of China BlueChemical Ltd. (3983)?
The price-to-sales ratio of China BlueChemical Ltd. is 0.72 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of China BlueChemical Ltd. (3983)?
The dividend yield of China BlueChemical Ltd. is 7.3%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of China BlueChemical Ltd. (3983)?
The net margin of China BlueChemical Ltd. is 8.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of China BlueChemical Ltd. (3983)?
The return on equity (ROE) of China BlueChemical Ltd. is 4.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of China BlueChemical Ltd. (3983)?
On an EBIT basis the return on assets of China BlueChemical Ltd. is 6.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of China BlueChemical Ltd. (3983)?
The operating margin of China BlueChemical Ltd. is 4.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at China BlueChemical Ltd. (3983)?
Revenue at China BlueChemical Ltd. is down 3.9% versus a year earlier (3y avg −5.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at China BlueChemical Ltd. (3983)?
Earnings per share at China BlueChemical Ltd. are down 20.8% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does China BlueChemical Ltd. (3983) carry?
The net debt of China BlueChemical Ltd. is 1.3B CNY (fiscal year 2025, ≈ 1.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch China BlueChemical Ltd. in the live analysis

One click puts China BlueChemical Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.